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Abstract
Purpose—To characterize microaneurysm closure following focal laser photocoagulation in
diabetic macular edema (DME) using simultaneous fluorescein angiography (FA) and spectral-
domain optical coherence tomography (SD-OCT)
Design—Retrospective observational case series.
Methods—Leaking microaneurysms (N=123) were analyzed in eyes (N=29) with
nonproliferative diabetic retinopathy (NPDR) which underwent navigated focal laser
photocoagulation in DME and followed at 3, 6, and 12 months. Closure of diabetic
microaneurysms was characterized in detail following focal laser using SD-OCT.
Results—Closure rate of microaneurysms by both FA and SD-OCT was 69.9% (84/123), 79.7 %
(98/123) and 82.9% (102/123) at 3, 6, and 12 months, respectively. Microaneurysm closure rate
increased at 6 and 12 months compared to 3 months (P < .003, P < .001). Over half of closed
microaneurysms (45/86, 52.3 %) left hyper-reflective spots while remaining half (41/86, 47.7 %)
disappeared without any hyper-reflectivity by SD-OCT at 3 months. Hyper-reflective spots
decreased at 6 (36/99, 36.4%) and 12 months (17/102, 16.7 %) with a concomitant increase in
complete loss of reflectivity at 6 (63/99, 63.6 %) and 12 months (85/102, 83.3%). Smaller outer
and inner diameters, and heterogeneous lumen reflectivity were positively associated with
microaneurysm closure at 12 months (P < .0001, P < .001, P < .03).
Conclusions—Characterization of microaneurysms following focal laser photocoagulation
resulted in hyper-reflective spots and complete resolution of all reflectivity using SD-OCT.
Smaller microaneurysms and those with heterogeneous lumen were positively associated with
microaneurysm closure. These findings provide greater understanding of localized retinal changes
following focal laser photocoagulation in DME treatment.
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Introduction
Diabetic macular edema (DME) is the most common cause of moderate vision loss in
patients with diabetic retinopathy (DR).1 Vision loss is a result of the leakage of blood
constituents from microaneurysms into the surrounding intra-retinal space which leads to
retinal thickening and macular edema with image distortion.2
Histologic findings of microaneurysms in DR include pericyte loss, endothelial proliferation
and apoptosis, and remodeling of basement membranes. These microaneurysms are found in
close association with focal areas of capillary non-perfusion with a majority in the inner
nuclear layer but also occasionally outer plexiform layer seen by electron microscopy.3
Since the Early Treatment Diabetic Retinopathy Study (ETDRS) for diabetic macular
edema, focal/grid laser photocoagulation has been the mainstay of treating DME4,5 with
fluorescein angiography (FA) guidance. More recently, the additional therapy with
intravitreal anti-vascular endothelial growth factor (VEGF) antibody has increased treatment
efficacy.6
Focal laser photocoagulation is thought to close microaneurysms directly which
subsequently stops leakage of blood constituents into retinal space. Focal treatment is
associated with reduction of macular edema in the occurrence of retinal thickening involving
the center of macula.4 However, recurrence of DME is not uncommon and can be very
difficult to treat despite multiple sessions of focal /grid laser photocoagulation. Difficulty in
managing DME reflects our limited understanding of the pathophysiology of regressing
microaneurysms following treatment. For decades, clinical evaluations of microaneurysms
in DME were confined to fundus photography and FA. Even with the development of time-
domain optical coherence tomography, individual details could not be appreciated.
More recently, visualization of diabetic microaneurysms has been characterized using
spectral-domain optical coherence tomography (SD-OCT).7,8 Characterization of individual
microaneurysms in DME following focal laser photocoagulation may increase our
understanding of microaneurysm regression and provide insight to improve treatment
approaches. In this study, we characterized individual microaneurysms in DME using
simultaneous FA and SD-OCT following navigated focal laser photocoagulation.
Methods
Study design
We retrospectively assessed 123 microaneurysms by simultaneous FA and SD-OCT in 21
consecutive patients with nonproliferative proliferative diabetic retinopathy (NPDR) treated
with navigated laser photocoagulation for DME at a single institution from November 2009
to January 2011. All treated microaneurysms which were visualized by FA and transected
by a raster scan using SD-OCT were included in this study. Patients included 18 males and 3
females with an average age of 61.0 ± 14.5 years. A total of 29 eyes with mild (6/29),
moderate (13/29), and severe (10/29) NPDR were followed at 3, 6, and 12 months following
a single session of navigated laser photocoagulation performed within 7 days of baseline
examination. At each visit, all patients underwent an ophthalmological examination with
imaging studies including simultaneous FA and SD-OCT. Patients with proliferative
diabetic retinopathy (PDR), poorly controlled diabetes (Hgb A1C > 8.0 %), or poorly
controlled hypertension (BP >140/90) were excluded. Eyes which did not undergo
simultaneous FA and SD-OCT for all time points or received conventional laser
photocoagulation were also excluded. Eyes which received any intravitreal steroid injection
in the study eye or any intravitreal anti-VEGF in the study eye or contralateral eye within 6
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months prior to receiving navigated laser photocoagulation or during the follow up period
were also excluded. This study adhered to the tenets of Declaration of Helsinki for research
involving human subjects and was performed in compliance to the Institutional Review
Board of the University of California, San Diego.
Simultaneous fluorescein angiography and SD-OCT
Simultaneous FA and SD-OCT images were acquired using the Spectralis HRA2
(Heidelberg Engineering, Carlsbad, CA) at each time points using the TruTrack™ Active
Eye Tracking software of the device to co-localize angiographic findings with SD-OCT
images. On FA, microaneurysm leakage was defined as a hyperfluorescent spot seen in early
phase with increasing hyperfluorescence in late phase.9 Extent of microaneurysm leakage
was graded as mild (score=1), moderate (score=2), or severe (score=3) leakage at each time
point by two masked retina specialists. Closed microaneurysms by FA following laser
photocoagulation were defined as an absence of focal hyperfluorescence in both early and
late phases.
High resolution SD-OCT images were acquired using a raster scan mode (20 × 20 degrees,
97 horizontal B-scans) during simultaneous FA imaging. Microaneurysms were detected as
circular structures on SD-OCT which coincided with leakage on FA images. The follow-up
scanning feature permitted reproducible SD-OCT image localization to characterize each
microaneurysm over time. The follow-up feature has been validated by Spectralis HRA2
(Heidelberg Engineering, Carlsbad, CA) using retinal vessel landmarks to determine
tracking information. SD-OCT images through the center of the microaneurysms were used
to characterize leaking microaneurysms by two masked retina specialists.
Microaneurysm size was characterized by averaging the horizontal and vertical diameters of
the outer and the inner wall (lumen) of each microaneurysm. Wall thickness was calculated
as : wall thickness = (outer diameter of microaneurysm - inner diameter of MA)/2. All direct
measurements were made using an internal caliper from the Spectralis HRA2. Central
macular thickness within 500 μm of the fovea and retinal thickness (RT) through the center
of each microaneurysm were calculated from software in SD-OCT after localizing the center
of fovea and the center of each MA. We determined the retinal layer in which the center of
the microaneurysm was located. Reflectivity within the lumen of each microaneurysm was
also determined to be heterogeneous or homogeneous based on the presence or absence of
hyper-reflective spots on SD-OCT. Using SD-OCT, a closed microaneurysm following laser
photocoagulation was defined as a microaneurysm with an absence or disappearance of a
previously open lumen.
Navigated focal laser photocoagulation
To maximize treatment accuracy, leaking diabetic microaneurysms (N=123) were treated
with focal laser photocoagulation (532 nm) using Navilas® (OD-OS, Teltow, Germany)
within 7 days of examination at baseline. The navigated retinal laser photocoagulator has
been used to increase accuracy to targeting microaneurysms and higher hit rate was
reported.10 Multi-modality imaging (infrared, color, fluorescein angiography) integrated
with a laser allowed planning and recording of treated areas. Eye tracking registration linked
to the laser photocoagulator ensured accurate delivery of laser pulses in coordination with
patient eye movements. In the present study, planning and treatment delivery of laser
photocoagulation was performed by a single retina specialist who did not participate in the
masked observations. Laser photocoagulation was performed with the following parameters:
spot size = 100–130 μm, duration = 100 ms, power = 70–150 mW. Laser burn intensity was
adjusted to achieve a gray-white burn by looking interchangeably at both real-time infrared
and color images during treatment.
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Statistical analysis
Statistical analysis was performed using SAS statistical software (Version 9.2, SAS Inc,
Cary, NC). Continuous variables were expressed as mean ± standard deviation (SD). A
paired t test or t test, and MacNemar′s test or Chi-square test were used to compare
continuous and categorical variables, respectively. Pearson′s correlations were also
performed among baseline characteristics. Since more than one microaneurysm were studied
per eye, microaneurysm closure was used as a binary variable and analyzed using
generalized estimation equations (GEE) to find significant predictors and to avoid any bias
due to intrapatient or intra-eye correlations. Microaneurysm characteristics and
microaneurysm closure by FA and SD-OCT were accessed by two masked retina specialists
who did not perform laser photocoagulation. Agreement between two masked observers was
assessed by calculating the concordant efficiency (Cohen′s kappa coefficient). A P-value < .
05 was considered to be statistically significant.
Results
Baseline characteristics of diabetic microaneurysms
Leaking microaneurysms (N=123) were characterized in 29 eyes (21 patients) with DME at
baseline using simultaneous FA and SD-OCT (Table 1). Microaneurysms included those of
mild (29/123, 23.6 %), moderate (49/123, 39.8 %) and severe (45/123, 36.6 %) NPDR. All
microaneurysms (123/123) were noted to have leakage with a moderate mean leakage score
(2.3 ± 0.6) by FA. Using SD-OCT, mean central macular thickness within 500 μm of the
fovea was found to be 361 ± 133 μm. Most of the studied microaneurysms were located in
the inner nuclear layer (INL)/ inner plexiform layer (IPL) (94/123, 76.4 %). A small number
of microaneurysms were found in the retinal nerve fiber layer (RNFL)/ ganglion cell layer
(GCL)(11/123, 8.9 %) and outer nuclear layer (ONL)/ outer plexiform layer (OPL)(18/123,
14.6 %). Microaneurysm size was characterized by their outer and inner diameters, and wall
thickness which resulted in 95 ± 27 μm, 59 ± 21 μm, and 18 ± 6 μm, respectively. Retinal
thickness through the center of each microaneurysm averaged 422 ± 89 μm. Using SD-
OCT, reflectivity within leaking microaneurysms was also characterized (Figure 1). Almost
three-quarters of all microaneurysms (91/123, 74%) had a lumen with homogeneous
reflectivity compared to one-quarter (32/123, 26%) with heterogeneous reflectivity.
As expected, increased FA leakage was associated with increased central macular thickness
(P < .05) and increased retinal thickness through the center of leaking microaneurysms (P < .
05) at baseline. Additionally, increased retinal thickness through the center of
microaneurysms also correlated with increased central macular thickness (P < .001).
Interestingly, increased FA leakage was associated with increased microaneurysm outer and
inner diameter (P < .0001, P < .0001) as well increased wall thickness (P <). Not
surprisingly, increased outer diameters of microaneurysms also correlated with an increased
inner diameter (P < .0001) and increased wall thickness (P < .0001).
Closure rate of microaneurysms
Microaneurysm closure following navigated laser photocoagulation at 3, 6, and 12 months
was assessed using simultaneous FA and SD-OCT by two masked retina specialists (Table
2). The microaneurysm closure rate was increased at 6 and 12 months compared to 3 months
by FA alone, SD-OCT alone, and both FA and SD-OCT. By FA alone, the microaneurysm
closure rate was 72.4 % (89/123), 83.7 % (103/123), and 84.6 % (104/123) at 3, 6, and 12
months, respectively. A significant increase in microaneurysm closure was observed at 6
and 12 months compared to 3 months (P < .003, P < .002). However, no significant increase
in microaneurysm closure was observed at 12 months compared to 6 (P > .05).
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Similarly, evaluation by SD-OCT alone resulted in a microaneurysm closure rate of 70.0 %
(86/123), 80.5 % (99/123), and 82.9 % (102/123) at 3, 6, and 12 months, respectively. A
significant increase in microaneurysm closure was also observed at 6 and 12 months
compared to 3 months (P < .004, P < .003) with no differnce in microaneurysm closure rate
to 3 months compared to 6 months (P > .05). Overall, there was no difference in
microaneurysm closure rate between FA alone and SD-OCT alone at all time points (P > .
05).
Microaneurysm closure rate seen using both FA and SD-OCT similarly paralleled FA alone
and SD-OCT alone. The microaneurysm closure rate seen by both FA and SD-OCT was
69.9 % (84/123), 79.7 % (98/123), and 82.9 % (102/123) at 3, 6, and 12 months,
respectively. A significant increase in microaneurysm closure by both FA and SD-OCT was
observed at 6 and 12 months compared to 3 months (P < .003, P < .001). No difference in
microaneurysm closure at 12 months compared to 6 months was observed using FA and SD-
OCT together (P > .05). Microaneurysm closure agreement between the two masked
observers was 81.2 % – 83.2 % (Kappa = 0.85, P = .25)
Retinal thickness changes and closed microaneurysms characterized by SD-OCT
Decreased central macular thickness and retinal thickness was seen following navigated
focal laser photocoagulation at 12 months. Mean central macular thickness decreased by 49
± 133 μm (13.7 %) from 361 ± 133 μm (225 – 638 μm) at baseline to 311 ± 90 μm (214 –
604 μm) at 12 months after laser photocoagulation (P < .0001). Retinal thickness also
decreased by 71 ± 82 μm (16.8 %) from 422 ± 89 μm (285 – 725 μm) at baseline to 352 ±
78 μm (242 – 605 μm) at 12 months following laser photocoagulation (P < .0001).
Characterization of closed microaneurysms only using SD-OCT revealed that over half of
the closed microaneurysms (45/86, 52.3 %) left hyper-reflective spots in their original
location while the remaining half (41/86, 47.7 %) disappeared without any hyper-reflectivity
on SD-OCT at 3 months (Figure 2, Figure 3). Consistent with baseline distribution of
microaneurysms, a majority of hyper-reflective spots (37/45, 82.2 %) were found in INL/
IPL and less frequently in ONL/OPL (6/45, 13.3 %) and RNFL/GCL (2/45, 4.4 %).
Similarly, a majority of closed microaneurysms which left no reflectivity were found in
INL/IPL (31/41, 75.6 %), while the remainder were found in ONL/OPL (6/41, 14.6%) and
RNFL/GCL (4/41, 9.8 %). Interestingly, microaneurysms which left hyper-reflective spots
decreased at 6 months (36/99, 36.4%) and 12 months (17/102, 16.7 %) compared to 3
months (45/86, 52.3%) (P < .003). A part of these hyper-reflective spots underwent
complete loss of reflectivity at 6 (16/45, 35.6 %) and 12 months (21/36, 58.3 %).
Conversely, the absence of reflectivity was increased at 6 months (63/99, 63.6 %) and 12
months (85/102, 83.3 %) compared to 3 months (41/86, 47.7 %) (P < .001).
A small number of microaneurysms which initially closed as hyper-reflective spots on SD-
OCT at 3 months were observed to reopen at the original location following navigated laser
photocoagulation (3/45, 6.7 %) (Figure 4). At 6 and 12 months, two and one microaneurysm
respectively were observed to reopen by SD-OCT. All three of these microaneurysms which
reopened were found to leak by FA. None of the closed microaneurysms which resulted in
absence of hyper-reflectivity following laser photocoagulation subsequently re-opened or
became hyper-reflective spots.
Baseline characteristics associated with microaneurysm closure at 12 months
Since microaneurysm closure stabilized between 6 and 12 months with minimal reopening
of MAs, baseline characteristics associated with increased MA closure rate were analyzed
by both FA and SD-OCT at 12 months. Baseline outer diameters of closed microaneurysms
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was 87 ± 27 μm while the outer diameter of unclosed microaneurysms 134 ± 25 μm.
Baseline inner diameters of closed and unclosed microaneurysms were 52 ± 21 μm and 90 ±
23 μm, respectively. Smaller outer and inner diameters at baseline were associated with an
increased microaneurysm closure rate (P < .0001, P < .001, GEE).
Almost all microaneurysms with a heterogeneous lumen were closed (30/32, 93.8 %) at 12
months. Microaneurysms with a homogeneous lumen at baseline resulted in a lower closure
rate at 12 months following laser photocoagulation (72/91, 79.1 %). Microaneurysms which
contained a heterogeneous lumen at baseline correlated with an increased microaneurysm
closure rate at 12 months following laser photocoagulation (P < .03, GEE). Baseline outer
and inner diameter of heterogeneous microaneurysms were 93.5 ± 25.2 μm and 57.1 ± 23.6
μm, respectively. Baseline outer and inner diameter of homogeneous microaneurysms were
95.9 ± 27.5 μm and 59.5 ± 20.3 μm, respectively. No difference in outer and inner diameter
was observed between microaneurysms with a heterogeneous or homogeneous lumen (P > .
05, P > .05). No association was found between microaneurysm closure rate and patient
characteristics (age, sex) or other baseline microaneurysm characteristics (grade of DR, FA
leakage score, wall thickness, retinal thickness, and location).
Discussion
In this study, we characterized microaneurysm closure in diabetic macular edema following
navigated focal laser photocoagulation using simultaneous FA and SD-OCT.
Microaneurysm closure rate following navigated laser determined by FA alone (89/123, 72.4
%), SD-OCT alone (86/123, 70.0 %), and both FA and SD-OCT (84/123, 69.9 %) at 3
months was similar to prior results using conventional laser. 11 Interestingly, the
microaneurysm closure rate in this study, continued to increase at 6 months compared to 3
months evaluated by FA alone, SD-OCT alone and both FA and SD-OCT (P < .003, P < .
004, P < .003) and stabilized at 12 months across all methods of evaluation. Additionally,
both central macular thickness and retinal thickness at the location of microaneurysms were
significantly decreased compared to baseline following navigated focal laser
photocoagulation (P < .0001, P < .0001). Our finding of delayed microaneurysm closure is
consistent with decreased central subfield thickness reported as late as 8 months following a
single treatment of focal laser photocoagulation by the diabetic retinopathy clinical research
(DRCR) network.12
Baseline tomographical characteristics of leaking microaneurysms (outer and inner
diameter, wall thickness, retinal thickness) in this study were similar to those previously
reported.7 In patients with both NPDR and PDR, microaneurysm size did not correlate with
FA leakage in the prior study. However, in this study, increased microaneurysm size (outer
and inner diameter) and wall thickness correlated with increased FA leakage (P < .0001)
when microaneurysms in patients with NPDR were evaluated. This suggests that MA size
may have a greater influence on endothelial dysfunction in NPDR compared to PDR while
other factors may contribute more predominantly in PDR.
Leaking microaneurysms with a heterogeneous lumen were associated with an increased
closure rate following navigated laser photocoagulation (P < .03). Prior studies have
suggested that the hyper-reflective spots seen with SD-OCT in heterogeneous
microaneurysm lumens are consistent with cellular components8 such as erythrocytes,
leukocytes, and lipid deposits seen by electron microscopy.13 Increased hemoglobin
containing cellular components increases laser absorption14–16 and may subsequently
increase the rate of microaneurysm closure in those with a heterogeneous lumen. In addition,
smaller baseline outer and inner diameters of microaneurysms were associated with
increased closure rate at 12 months (P < . 0001, P < . 001). It is not surprising that smaller
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microaneurysms with a higher heat absorption to surface area ratio may be more amenable
to closure following laser photocoagulation.
Furthermore, leaking microaneurysms which initially closed at 3 months following laser
photocoagulation resulted in either hyper-reflective spots (45/86, 52.3 %) or absence of
reflectivity (41/86, 47.7 %) on SD-OCT. Interestingly, some of these hyper-reflective spots
further underwent complete loss of reflectivity at 6 months (16/45, 35.6 %) and 12 months
(21/36, 58.3%). As the number of hyper-reflective spots decreased, the number of closed
microaneurysms which resulted in complete loss of all reflectivity increased. Initial
tomographical changes of a microaneurysm following laser photocoagulation, may be
closure and collapse of its lumen to hyper-reflective spots with eventual resorption and
disappearance of all reflectivity. Moreover, areas which lost all reflectivity never re-
accumulated hyper-reflective spots. Complete loss of reflectivity observed by SD-OCT
following focal laser may represent permanent microaneurysm closure with complete
resorption of cellular components and lipid deposits. A small number of microaneurysms
which were replaced with hyper-reflective spots were observed to re-open (3/45, 6.7 %),
while no re-opening was seen in areas of absence of residual reflectivity. Furthermore, re-
open microaneurysms seen by SD-OCT was confirmed as leakage by FA. Although these
numbers are small, hyper-reflective spots may represent collapsed microaneurysms which
have the potential to re-open if there is no further cellular remodeling and resorption. A
large prospective trial to monitor a greater number of microaneurysms following focal laser
would provide a better understanding of the SD-OCT characteristics of microaneurysms
prone to re-open and subsequently identify earlier need for re-treatment prior to the
development of overt macular edema.
In summary, we have identified SD-OCT characteristics of microaneurysms which increase
closure rate and resolution of DME following navigated laser photocoagulation.
Furthermore, we have characterized SD-OCT changes in microaneurysms during the course
of microaneurysm closure following laser treatment as well as re-opening of a small number
of initially closed microaneurysms. Detailed tomographical characteristics of closed
microaneurysms following focal laser may improve our understanding of localized retinal
changes which may lead to permanent microaneurysm closure, or may provide early
detection of need for re-treatment.
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Figure 1.
Lumens of leaking retinal microaneurysms characterized by simultaneous fluorescein
angiography (FA) and spectral-domain optical coherence tomography (SD-OCT)
Representative simultaneous FA (left) and SD-OCT images (right) of leaking
microaneurysms (white and open arrow) are seen in the inner nuclear layer with adjacent
intra-retinal cystic edema. The microaneurysm lumen with homogeneous reflectivity (top
right, white arrow) has uniform reflectivity unlike the microaneurysm lumen with
heterogeneous reflectivity (bottom right, open arrow) which contains irregular hyper-
reflective spots.
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Figure 2.
Retinal microaneurysms characterized by spectral-domain optical coherence tomography
following focal laser photocoagulation
Leaking microaneurysms with a heterogeneous lumen (white and open arrows, top) in the
inner nuclear layer with adjacent cystic edema were observed at baseline. At 6 months
following navigated focal laser photocoagulation (bottom), a heterogeneous microaneurysm
(white arrow) closed leaving hyper-reflective spots in its original location with resolution of
adjacent cystic edema (bottom left). Another heterogeneous microaneurysm (open arrow)
closed leaving an absence of any reflectivity following 6 months after laser
photocoagulation (bottom right).
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Figure 3.
Progression of retinal microaneurysm closure characterized by spectral-domain optical
coherence tomography following focal laser photocoagulation
Microaneurysm with homogeneous lumen (white arrow) was observed in the inner nuclear
layer with adjacent cystic fluid (top). At 3 months following focal laser photocoagulation,
the microaneurysm has a persistently open lumen with cystic fluid (second row). At 6
months, the microaneurysm lumen has closed collapsing with decreased cystic fluid (third
row). At 12 months (bottom), the lumen has been obliterated with leaving hyper-reflective
spots in its original location with resolution of intra-retinal fluid.
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Figure 4.
Initially closed retinal microaneuryms may re-open following focal laser photocoagulation
At baseline, a microaneurysm with a heterogeneous lumen (white circle) was observed in
the inner nuclear layer with adjacent cystic fluid (top). At 3 months following focal laser
photocoagulation, the microaneurysm has a persistently open lumen with decreased
surrounding intra-retinal cystic fluid (second row). Disruption of the outer retina and retinal
pigment epithelium by laser photocoagulation is also seen. At 6 months, the microaneurysm
lumen has collapsed leaving hyper-reflective spots in its original location with resolution of
adjacent intra-retinal fluid (third row). At 12 months, the microaneurysm has re-opened in
the same location where hyper-reflective spots were seen previously (bottom).
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Table 1
Baseline characteristics of retinal microaneurysms
Baseline characteristic Mean (μm) ± SD (range)
FA leakage score 2.3 ± 0.6 (1–3)
Outer diameter 95 ± 27 (60–186)
Inner diameter 59 ± 21 (25–152)
Wall thickness 18 ± 6 (5–36)
Retinal thickness 422 ± 89 (285–725)
Retinal layer N/123 (%)
 RNFL/GCL 11 (8.9)
 INL/IPL 94 (76.4)
 ONL/OPL 18 (14.6)
Lumen reflectivity N/123 (%)
 Homogeneous 91 (74.0)
 Heterogeneous 32 (26.0)
Grade of DR N/123 (%)
 Mild NPDR 29 (23.6)
 Moderate NPDR 49 (39.8)
 Severe NPDR 45 (36.6)
SD = standard deviation, FA = fluorescein angiography, RNFL/GCL = retinal nerve fiber layer/ganglion cell layer, INL/IPL = inner nuclear layer/
inner plexiform layer, ONL/OPL = outer nuclear layer/outer plexiform layer, DR = diabetic retinopathy, NPDR = nonproliferative diabetic
retinopathy
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Table 2
Closure rate of retinal microaneurysms
Assessment
3 months 6 months 12 months
N/123 (%) N/123 (%) N/123 (%)
FA Alone 89 (72.4) 103 (83.7) 104 (84.6)
SD-OCT Alone 86 (70.0) 99 (80.5) 102 (82.9)
Both FA and SD-OCT 84 (69.9) 98 (79.7) 102 (82.9)
FA = fluorescein angiography, SD-OCT = spectral-domain optical coherence tomography MA closure rate was increased at 6 months (P < .003, P
< .004, P < .003) and 12 months (P < .002, P < .003, P < .001) compared to 3 months by FA alone, SD-OCT alone, and both FA and SD-OCT.
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